前列腺导管腺癌中导管成分比例对预后的意义
回顾性分析2005至2014年在本院接受根治性前列腺切除术的3038例前列腺癌患者,排除接受新辅助或辅助治疗者。2648例中101例(3.8%)为导管腺癌,其无生化复发生存显著低于腺泡腺癌(p<0.001);导管成分≥30%组无生化复发生存显著低于<30%组(p=0.023),高导管成分是生化复发的显著预测因子(p<0.001)。
要点
- 导管腺癌患者无生化复发生存显著低于腺泡腺癌(p<0.001)。
- 导管成分≥30%组无生化复发生存显著低于<30%组(p=0.023)。
- 高导管成分是生化复发的显著预测因子(p<0.001)。
核心结论
- 导管腺癌的预后可按导管成分比例进行分层,该标志物可能作为不良预后的替代指标或辅助治疗的决定因素。
研究设计与样本
- 回顾性队列研究,纳入2005至2014年在本院接受根治性前列腺切除术的3038例前列腺癌患者,排除接受新辅助或辅助治疗者,最终分析2648例。
主要发现
- 2648例中101例(3.8%)为导管腺癌,2547例(96.2%)为腺泡腺癌。
- 导管腺癌患者无生化复发生存显著低于腺泡腺癌患者(p<0.001)。
- 导管成分≥30%组无生化复发生存显著低于<30%组(p=0.023)。
- 单因素和多因素Cox回归分析显示,高导管成分是生化复发的显著预测因子(p<0.001)。
关键数值与推荐
- 导管成分比例分层阈值为30%(≥30% vs <30%)。
- 高导管成分预测生化复发的p<0.001。
临床怎么用
- 作者认为导管成分比例可用于导管腺癌的预后分层,并可能作为不良预后的替代指标或辅助治疗的决定因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In prostate cancer ductal adenocarcinoma is mixed with the usual acinar adenocarcinoma. However, to our knowledge whether the proportion of the ductal component affects oncologic outcomes is currently unknown. We investigated whether the proportion of the ductal component predicts oncologic outcomes in ductal adenocarcinoma. MATERIALS AND METHODS: We retrospectively reviewed clinical data on 3,038 patients with prostate cancer who underwent radical prostatectomy at our institution between 2005 and 2014. We excluded patients who received neoadjuvant or adjuvant treatment. Patients were stratified based on the proportion of the ductal component. We compared the probability of biochemical recurrence between groups and investigated how the proportion of the ductal component influences biochemical recurrence using Kaplan-Meier estimates and Cox regression models, respectively. RESULTS: Of 2,648 patients 101 (3.8%) had ductal adenocarcinoma and 2,547 (96.2%) had acinar adenocarcinoma. Freedom from biochemical recurrence in patients with ductal adenocarcinoma was significantly lower than in those with acinar adenocarcinoma (p <0.001). When ductal cases were stratified by the proportion of the ductal component, freedom from biochemical recurrence in the high ductal component group was significantly lower compared to that in the low ductal component group (30% or greater vs less than 30%, p = 0.023). On univariate and multivariate Cox regression analyses, a high ductal component was a significant predictor of biochemical recurrence (p <0.001). CONCLUSIONS: The prognosis for ductal adenocarcinoma can be stratified by the proportion of the ductal component. This marker could potentially be used as a surrogate for poor prognosis or as a determinant for adjuvant therapy.
引用
- Jang WS, Shin SJ, Yoon CY, et al. Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate. J Urol. 2016. PMID: 27916712. doi:10.1016/j.juro.2016.11.104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。